Garwood Medical Devices (GMD) is a medical device company with a core mission: "To Advance Infection Control Through Innovation.
Garwood has patented technologies that provide effective, efficient and measurable electrical stimulation treatments for chronic wound healing, bone growth and peri-prosthetic infection.
Garwood Medical Devices was founded in July 2014, by Wayne Bacon and Brian Peterson. The company is headquartered in Buffalo, New York.
Garwood Medical is committed to disrupt the wound care and perio-prosthetic market by advancing infection control through innovation.
Garwood specializes in healthcare innovation and holds the exclusive license for the core BioPrax technology developed by the University at Buffalo. The company currently holds 8 registered and pending patents.
The Garwood device solutions in development focus on improving patients’ outcomes by focusing on treating the wound and allow for remote monitoring (EnerAid®), Fight infections on implants including those antibiotic resistant (CVCWI), and expedite healing of bone and enhance wound healing.
Garwood Medical is backed by The WNY Impact Investment Fund, The Murray Family, along with other undisclosed investors. The company raised $4M in Series C round on Aug 20, 2020. This brings Garwood's total funding to to $11.3M to date.